SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-17-004001
Filing Date
2017-07-07
Accepted
2017-07-07 16:40:25
Documents
1
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT formfour.html 4  
1 OWNERSHIP DOCUMENT formfour.xml 4 3674
  Complete submission text file 0001171843-17-004001.txt   5037
Mailing Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850
Business Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850 3019613400
Sucampo Pharmaceuticals, Inc. (Issuer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SUCAMPO PHARMACEUTICALS 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850
Business Address
Driggs Alex (Reporting) CIK: 0001708997 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33609 | Film No.: 17955589